772 results on '"Congenital Heart Disease"'
Search Results
2. Management of arrhythmias during pregnancy.
- Author
-
Albertini, Lisa and Spears, Danna A.
- Subjects
ARRHYTHMIA ,HEART diseases in women ,ARRHYTHMOGENIC right ventricular dysplasia ,CONGENITAL heart disease ,ATRIAL arrhythmias ,PREGNANCY - Published
- 2024
- Full Text
- View/download PDF
3. Non-cardiac birth defects and long-term risk of cardiovascular hospitalisation.
- Author
-
Auger, Nathalie, Paradis, Gilles, Healy-Profitós, Jessica, Lewin, Antoine, Malik, Mariyam, and Potter, Brian J.
- Subjects
CONGENITAL disorders ,HUMAN abnormalities ,HEART failure ,CARDIOVASCULAR diseases risk factors ,CONGENITAL heart disease ,PALATE surgery ,HOSPITAL care ,MECKEL diverticulum - Published
- 2024
- Full Text
- View/download PDF
4. Heart rate: an accessible risk indicator in adult congenital heart disease.
- Author
-
Hendriks, Paul M., van den Bosch, Annemien E., Kors, Jan A., Geenen, Laurie W., Baggen, Vivan J. M., Eindhoven, Jannet A., Kauling, Robert M., Cuypers, Judith A. A. E., Boersma, Eric, and Roos-Hesselink, Jolien W.
- Subjects
TRANSPOSITION of great vessels ,VENTRICULAR ejection fraction ,HEART failure ,HEART beat ,CONGENITAL heart disease - Abstract
This article discusses a study on the association between heart rate and mortality and heart failure in adult patients with congenital heart disease (ACHD). The study found that higher heart rates were significantly associated with lower survival and heart failure-free survival in ACHD patients. The study suggests that heart rate should be considered as a risk indicator in ACHD and further research is needed to determine if it is a risk factor. The article provides detailed information on the study design, data collection, and statistical analysis. It also highlights the potential of wearable devices, such as smartwatches, to monitor heart rate and aid in clinical follow-up and risk stratification. Overall, the study suggests that heart rate may play an important role in the management of heart disease. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
5. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease.
- Author
-
Luna-Lopez, Raquel, Segura de la Cal, Teresa, Sarnago Cebada, Fernando, Martin de Miguel, Irene, Hinojosa, Williams, Cruz-Utrilla, Alejandro, Velazquez, Maria Teresa, Delgado, Juan F., Mendoza, Alberto, Arribas Ynsaurriaga, Fernando, and Escribano-Subías, Pilar
- Subjects
PULMONARY arterial hypertension ,CONGENITAL heart disease ,INFORMED consent (Medical law) ,ATRIAL septal defects ,PATIENT selection ,TRANSPOSITION of great vessels ,PULMONARY hypertension - Published
- 2024
- Full Text
- View/download PDF
6. Peak oxygen consumption by smartwatches compared with cardiopulmonary exercise test in complex congenital heart disease.
- Author
-
Tran, Tomio, Steiner, Jill Marie, Venkateswaran, Aparajithan, and Buber, Jonathan
- Subjects
EXERCISE tests ,CONGENITAL heart disease ,OXYGEN consumption ,SMARTWATCHES ,TRANSPOSITION of great vessels ,HEART beat ,AEROBIC capacity - Published
- 2024
- Full Text
- View/download PDF
7. Comprehensive imaging in patients with suspected pulmonary arterial hypertension.
- Author
-
Crisan, Simina, Baghina, Ruxandra-Maria, Luca, Silvia Ana, Cozlac, Alina-Ramona, Negru, Alina-Gabriela, Vacarescu, Cristina, Lazar, Mihai-Andrei, Luca, Constantin-Tudor, and Gaita, Dan
- Subjects
PULMONARY arterial hypertension ,HEREDITARY hemorrhagic telangiectasia ,HEART failure ,COMPUTED tomography ,CARDIAC magnetic resonance imaging ,CONGENITAL heart disease ,POSITRON emission tomography - Published
- 2024
- Full Text
- View/download PDF
8. Outcomes after implantation of right-sided mechanical valve prostheses in congenital heart disease.
- Author
-
Abozied, Omar, Miranda, William, Younis, Ahmed, Burchill, Luke, Jain, Charles, Connolly, Heidi, Dearani, Joseph, Stephens, Elizabeth H, and Egbe, Alexander C.
- Subjects
PROSTHETIC heart valves ,CONGENITAL heart disease ,ATRIAL flutter ,MECHANICAL hearts ,THERAPEUTIC embolization ,STRUCTURAL failures ,TRANSPOSITION of great vessels ,BIOPROSTHETIC heart valves - Published
- 2023
- Full Text
- View/download PDF
9. Transcatheter closure of atrial septal defect in the elderly: a systematic review and meta-analysis.
- Author
-
Baroutidou, Amalia, Arvanitaki, Alexandra, Farmakis, Ioannis T., Patsiou, Vasiliki, Giannopoulos, Andreas, Efthimiadis, Georgios, Ziakas, Antonios, and Giannakoulas, George
- Subjects
ATRIAL septal defects ,ARRHYTHMIA ,OLDER people ,TRICUSPID valve insufficiency ,CARDIAC hypertrophy ,CONGENITAL heart disease ,ATRIAL arrhythmias ,TRICUSPID valve surgery - Published
- 2023
- Full Text
- View/download PDF
10. Right-sided mechanical valve prostheses in adults with congenital heart disease.
- Author
-
Galligan, John and Brida, Margarita
- Subjects
CONGENITAL heart disease ,MECHANICAL hearts ,PROSTHETICS ,PROSTHETIC heart valves ,VALVES ,BIOPROSTHETIC heart valves ,INFECTIVE endocarditis - Published
- 2023
- Full Text
- View/download PDF
11. Double outlet ventricles: review of anatomic and imaging characteristics.
- Author
-
Zhuoyuan Xu, Semple, Thomas, Hong Gu, McCarthy, Karen P., Siew Yen Ho, and Wei Li
- Subjects
TRANSPOSITION of great vessels ,VENTRICULAR septal defects ,TETRALOGY of Fallot ,CONGENITAL heart disease ,LEFT heart ventricle ,HEART septum ,VENTRICULAR remodeling - Published
- 2023
- Full Text
- View/download PDF
12. COVID-19 international experience in paediatric patients with congenital heart disease.
- Author
-
Yeh, Mary J., Bergersen, Lisa, Gauvreau, Kimberlee, Barry, Oliver M., Batlivala, Sarosh P., Bjornlund, Elsa, Boe, Brian, Fernando Caneo, Luiz, Croti, Ulisses A., Doyle, Thomas, Furnaz, Shumaila, Cesar Moraes, Rodrigo, O'Byrne, Michael L., de Oliveira Paes, Erica, Palacios-Macedo, Alexis, Pechilkov, Dimitar, Fernando Sandoval, Nestor, Sen, Supratim, Stajevic, Mila, and Ferreira Travessa, Marco Antonio
- Subjects
CHILD patients ,CONGENITAL heart disease ,CARDIAC patients ,ARRHYTHMIA ,COUGH ,PATIENTS' attitudes ,CARDIAC magnetic resonance imaging - Published
- 2023
- Full Text
- View/download PDF
13. Prognostic implications of atrial fibrillation in adults with Ebstein anomaly.
- Author
-
de Miguel, Irene Martin, Madhavan, Malini, Miranda, William R., Connolly, Heidi M., Egbe, Alexander C., and Martin de Miguel, Irene
- Subjects
ATRIAL flutter ,HEART failure ,EBSTEIN'S anomaly ,PROGNOSIS ,ATRIAL fibrillation ,VENTRICULAR ejection fraction ,ADULTS ,CONGENITAL heart disease - Abstract
Objective: Supraventricular arrhythmias are common in adults with Ebstein anomaly (EA). However, there are limited data about prognostic implications of atrial fibrillation (AF) in this population. Accordingly, our aim was to assess the clinical profile and burden of AF in adults with EA, and the relationship between AF and outcomes.Methods and Results: Six hundred eighty-two consecutive adults with a median age of 36 (24-49) years from Mayo Clinic, Minnesota, USA, between 2003 and 2020 were included. Sustained episodes of AF, clinical, echocardiographic, rhythm and surgical data were collected. Prevalence of AF at baseline was 18% (126 patients); the first episode occurred at a mean age of 43±17 years. Patients with AF were older, were more likely men, and had hypertension, renal dysfunction, cardiac devices, and more advanced right-sided and left-sided remodelling. During a median follow-up of 156 (81-240) months, 62 patients (11%) developed incident AF. At the last encounter, prevalence of AF was 28% (188 patients); of those, 63 (34%) had recurrent AF. Hospitalisation for heart failure (HF) occurred in 51 patients (7%). AF (HR 2.32, 95% CI 1.18 to 4.47; p=0.01) was independently associated with hospitalisation for HF. All-cause death occurred in 53 patients (8%); it was more frequent in those with AF in the univariable analysis, although it did not remain significant in the multivariable analysis.Conclusions: AF in EA develops at relatively young ages with one-third of the cohort exhibiting a recurrent pattern. Patients with AF had a higher prevalence of comorbidities and worse right-sided and left-sided cardiac remodelling. AF was independently associated with HF hospitalisation. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
14. Major elective non-cardiac operations in adults with congenital heart disease.
- Author
-
Williamson, Catherine G., Ebrahimian, Shayan, Ascandar, Nameer, Sanaiha, Yas, Sakowitz, Sara, Biniwale, Reshma M., and Benharash, Peyman
- Subjects
CONGENITAL heart disease ,ELECTIVE surgery ,ENHANCED recovery after surgery protocol - Published
- 2023
- Full Text
- View/download PDF
15. How to plan and perform a diagnostic catheterisation in adult patients with congenital heart disease.
- Author
-
Steinberg, Zachary L. and Singh, Harsimran S.
- Subjects
TRANSPOSITION of great vessels ,CONGENITAL heart disease ,CARDIAC patients ,OXIMETRY ,CEREBROSPINAL fluid shunts ,VENTRICULAR outflow obstruction ,PULMONARY circulation ,VENA cava inferior - Published
- 2023
- Full Text
- View/download PDF
16. Transfer of congenital heart patients from paediatric to adult services in England.
- Author
-
Pujol, Ferran Espuny, Franklin, Rodney C., Crowe, Sonya, Brown, Kate L., Swan, Lorna, Pagel, Christina, English, Kate M., and Espuny Pujol, Ferran
- Subjects
CONGENITAL heart disease diagnosis ,CONGENITAL heart disease ,RETROSPECTIVE studies - Abstract
Objective: This study assessed the transfer of patients from paediatric cardiac to adult congenital heart disease (ACHD) services in England and the factors impacting on this process.Methods: This retrospective cohort study used a population-based linked data set (LAUNCHES QI data set: 'Linking Audit and National datasets in Congenital Heart Services for Quality Improvement') including all patients born between 1987 and 2000, recorded as having a congenital heart disease (CHD) procedure in childhood. Hospital Episode Statistics data identified transfer from paediatric to ACHD services between the ages of 16 and 22 years.Results: Overall, 63.8% of a cohort of 10 298 patients transferred by their 22nd birthday. The estimated probability of transfer by age 22 was 96.5% (95% CI 95.3 to 97.7), 86.7% (95% CI 85.6 to 87.9) and 41.0% (95% CI 39.4 to 42.6) for severe, moderate and mild CHD, respectively. 166 patients (1.6%) died between 16 and 22 years; 42 of these (0.4%) died after age 16 but prior to transfer. Multivariable ORs in the moderate and severe CHD groups up to age 20 showed significantly lower likelihood of transfer among female patients (0.87, 95% CI 0.78 to 0.97), those with missing ethnicity data (0.31, 95% CI 0.18 to 0.52), those from deprived areas (0.84, 95% CI 0.72 to 0.98) and those with moderate (compared with severe) CHD (0.30, 95% CI 0.26 to 0.35). The odds of transfer were lower for the horizontal compared with the vertical care model (0.44, 95% CI 0.27 to 0.72). Patients who did not transfer had a lower probability of a further National Congenital Heart Disease Audit procedure between ages 20 and 30 compared with those who did transfer: 12.3% (95% CI 5.1 to 19.6) vs 32.5% (95% CI 28.7 to 36.3).Conclusions: Majority of patients with moderate or severe CHD in England transfer to adult services. Patients who do not transfer undergo fewer elective CHD procedures over the following decade. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
17. Management of Fontan failure.
- Author
-
D'Angelo, Emanuela Concetta, Ciuca, Cristina, Assenza, Gabriele Egidy, and Egidy Assenza, Gabriele
- Subjects
HEART failure ,ARRHYTHMIA ,VASCULAR remodeling ,LOW-molecular-weight heparin ,CONGENITAL heart disease ,RETROSPECTIVE studies ,CARDIOPULMONARY bypass - Published
- 2022
- Full Text
- View/download PDF
18. Outcomes among adult survivors of total cavopulmonary Fontan palliation for single ventricle.
- Author
-
Anigwe, Christopher, Yogeswaran, Vidhushei, Moon-Grady, Anita, McAllister, Sophie, Aggarwal, Anika, Blissett, Sarah, Harris, Ian S., Kouretas, Peter C., Mahadevan, Vaikom S., Sabanayagam, Aarthi, and Agarwal, Anushree
- Subjects
ARTHRITIS Impact Measurement Scales ,CONGENITAL heart disease ,RETROSPECTIVE studies ,TREATMENT effectiveness ,CARDIOPULMONARY bypass ,LONGITUDINAL method - Abstract
Objective: This tertiary centre study aims to identify factors associated with adverse outcomes in adult survivors with total cavopulmonary connection (TCPC) Fontan palliation for single ventricle.Methods: This retrospective review of medical records identified adult (≥18 years) survivors of TCPC Fontan palliation who were followed at a single tertiary centre between 1 January 2000 and 1 July 2019. Adverse outcomes were defined as arrhythmia, pacemaker/implantable cardioverter defibrillator placement, liver cirrhosis, protein losing enteropathy, hospitalisation for heart failure, thromboembolic complication and/or death.Results: 160 adult TCPC patients met the inclusion criteria: 117 (73.1%) extracardiac and 43 (26.9%) lateral tunnel. The median (IQR) duration of follow-up since TCPC palliation was 17.5 (11.8-21.3) years. An adverse outcome occurred in 87 (54.4%) patients. Adverse outcome-free survival rates at 10, 20 and 25 years post TCPC were 89% (95% CI 82% to 93%), 60% (95% CI 50% to 69%) and 24% (95% CI 15% to 35%), respectively. On multivariate analysis, extracardiac Fontan (HR 2.21, 95% CI 1.20 to 4.08, p=0.011) was observed to be an independent risk factor for adverse outcomes after adjusting for age, race, morphology of the systemic ventricle and history of fenestration.Conclusions: In this single-centre retrospective study of adult survivors of TCPC palliation, extracardiac Fontan was associated with an increased hazard for adverse outcomes. This finding could guide clinicians in developing risk modification strategies and management decisions to improve long-term outcomes in these patients. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
19. Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis.
- Author
-
Himelfarb, Jonah Daniel, Shulman, Healey, Olesovsky, Christopher James, Rumman, Rawan K., Oliva, Laura, Friedland, Joshua, Farrell, Ashley, Huszti, Ella, Horlick, Eric, and Abrahamyan, Lusine
- Subjects
ATRIAL fibrillation diagnosis ,CARDIAC catheterization ,RESEARCH ,META-analysis ,RESEARCH methodology ,SYSTEMATIC reviews ,ATRIAL fibrillation ,CONGENITAL heart disease ,DISEASE incidence ,EVALUATION research ,ATRIAL septal defects ,TREATMENT effectiveness ,COMPARATIVE studies ,DISEASE complications - Abstract
Objective: The ostium secundum atrial septal defect (ASD) is among the most common congenital cardiac anomalies diagnosed in adulthood. A known complication of transcatheter ASD closure is the development of new-onset atrial fibrillation and flutter (AFi/AFl). These arrhythmias confer an increased risk of postoperative stroke, thrombus formation and systemic emboli. This systematic review examines the burden of de novo AFi/AFl in adults following transcatheter closure and seeks to identify risk factors for AFi/AFl development.Methods: Studies were identified by a search of MEDLINE, EMBASE and Cochrane databases from inception until 29 April 2020. A meta-analysis of AFi/AFl incidence was performed using a random-effects model.Results: A total of 31 studies met inclusion criteria, comprising 4788 adult patients without a history of AFi/AFl. Twenty-three studies were included in quantitative synthesis and demonstrated an overall incidence rate of 1.82 patients per 100 person-years of follow-up (I2=83%). In studies that enrolled only patients ≥60 years old, the incidence was 5.21 patients per 100 person-years (I2=0%). Studies with follow-up duration ≤2 years reported an incidence of 4.05 per 100 person-years (I2=55%) compared with a rate of 1.19 per 100 person-years (I2=85%) for studies with follow-up duration >2 years.Conclusions: The incidence of new-onset AFi/AFl is relatively low following transcatheter closure of secundum ASDs. The rate of de novo AFi/AFl, however, was significantly higher in elderly patients. Shorter follow-up time was associated with a higher reported incidence of AFi/AFl. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
20. Cohort study of intervened functionally univentricular heart in England and Wales (2000-2018).
- Author
-
Hadjicosta, Elena, Franklin, Rodney, Seale, Anna, Stumper, Oliver, Tsang, Victor, Anderson, David R., Pagel, Christina, Crowe, Sonya, Pujol, Ferran Espuny, Ridout, Deborah, Brown, Kate L., and Espuny Pujol, Ferran
- Subjects
HEART ventricle abnormalities ,HEART septum abnormalities ,CONGENITAL heart disease ,RETROSPECTIVE studies ,HEART ventricles ,TREATMENT effectiveness ,RESEARCH funding ,LONGITUDINAL method - Abstract
Objective: Given the paucity of long-term outcome data for complex congenital heart disease (CHD), we aimed to describe the treatment pathways and survival for patients who started interventions for functionally univentricular heart (FUH) conditions, excluding hypoplastic left heart syndrome.Methods: We performed a retrospective cohort study using all procedure records from the National Congenital Heart Diseases Audit for children born in 2000-2018. The primary outcome was mortality, ascertained from the Office for National Statistics in 2020.Results: Of 53 615 patients, 1557 had FUH: 55.9% were boys and 67.4% were of White ethnic groups. The largest diagnostic categories were tricuspid atresia (28.9%), double inlet left ventricle (21.0%) and unbalanced atrioventricular septal defect (AVSD) (15.2%). The ages at staged surgery were: initial palliation 11.5 (IQR 5.5-43.5) days, cavopulmonary shunt 9.2 (IQR 6.0-17.1) months and Fontan 56.2 (IQR 45.5-70.3) months. The median follow-up time was 10.8 (IQR 7.0-14.9) years and the 1, 5 and 10-year survival rates after initial palliation were 83.6% (95% CI 81.7% to 85.4%), 79.4% (95% CI 77.3% to 81.4%) and 77.2% (95% CI 75.0% to 79.2%), respectively. Higher hazards were present for unbalanced AVSD HR 2.75 (95% CI 1.82 to 4.17), atrial isomerism HR 1.75 (95% CI 1.14 to 2.70) and low weight HR 1.65 (95% CI 1.13 to 2.41), critical illness HR 2.30 (95% CI 1.67 to 3.18) or acquired comorbidities HR 2.71 (95% CI 1.82 to 4.04) at initial palliation.Conclusion: Although treatment pathways for FUH are complex and variable, nearly 8 out of 10 children survived to 10 years. Longer-term analyses of outcome based on diagnosis (rather than procedure) can inform parents, patients and clinicians, driving practice improvements for complex CHD. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
21. Raising the bar: triple therapy for pulmonary arterial hypertension associated with congenital heart disease.
- Author
-
D'Alto, Michele and Bassareo, Pier Paolo
- Subjects
PULMONARY arterial hypertension ,CONGENITAL heart disease ,PULMONARY hypertension ,PULMONARY artery diseases ,EISENMENGER syndrome - Published
- 2024
- Full Text
- View/download PDF
22. Fluid challenge and balloon occlusion testing in patients with atrial septal defects.
- Author
-
D'Alto, Michele, Constantine, Andrew, Chessa, Massimo, Santoro, Giuseppe, Gaio, Gianpiero, Giordano, Mario, Romeo, Emanuele, Argiento, Paola, Wacker, Julie, D'Aiello, Angelo Fabio, Sarubbi, Berardo, Russo, Maria Giovanna, Naeije, Robert, Golino, Paolo, and Dimopoulos, Konstantinos
- Subjects
ATRIAL septal defect treatment ,ATRIAL septal defects ,VASCULAR resistance ,CATHETERIZATION ,HEMODYNAMICS ,LONGITUDINAL method ,DISEASE complications - Abstract
Introduction: Careful, stepwise assessment is required in all patients with atrial septal defect (ASD) to exclude pulmonary vascular or left ventricular (LV) disease. Fluid challenge and balloon occlusion may unmask LV disease and post-capillary pulmonary hypertension, but their role in the evaluation of patients with 'operable' ASDs is not well established.Methods: We conducted a prospective study in three Italian specialist centres between 2018 and 2020. Patients selected for percutaneous ASD closure underwent assessment at baseline and after fluid challenge, balloon occlusion and both.Results: Fifty patients (46 (38.2, 57.8) years, 72% female) were included. All had a shunt fraction >1.5, pulmonary vascular resistance (PVR) <5 Wood Units (WU) and pulmonary arterial wedge pressure (PAWP) <15 mm Hg. Individuals with a PVR ≥2 WU at baseline (higher PVR group) were older, more symptomatic, with a higher baseline systemic vascular resistance (SVR) than the lower PVR group (all p<0.0001). Individuals with a higher PVR experienced smaller increases in pulmonary blood flow following fluid challenge (0.3 (0.1, 0.5) vs 2.0 (1.5, 2.8) L/min, p<0.0001). Balloon occlusion led to a more marked fall in SVR (p<0.0001) and a larger increase in systemic blood flow (p=0.024) in the higher PVR group. No difference was observed in PAWP following fluid challenge and/or balloon occlusion between groups; four (8%) patients reached a PAWP ≥18 mm Hg following the addition of fluid challenge to balloon occlusion testing.Conclusions: In adults with ASD without overt LV disease, even small rises in PVR may have significant implications on cardiovascular haemodynamics. Fluid challenge may provide additional information to balloon occlusion in this setting. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
23. Cardiac audit, data and registries: evolution of a national programme.
- Author
-
Ratneswaren, Anenta, de Belder, Mark A., and Timmis, Adam
- Subjects
MYOCARDIAL infarction ,ST elevation myocardial infarction ,HEART valve prosthesis implantation ,CONGENITAL heart disease ,AUDITING ,CARDIOVASCULAR disease treatment ,ASSOCIATIONS, institutions, etc. ,HEART ,CARDIOVASCULAR diseases ,ACQUISITION of data ,PSYCHOLOGICAL tests ,IMPACT of Event Scale ,PSYCHOLOGICAL adaptation - Abstract
The UK is one of the few countries in the world with national registries that record key statistics across a broad range of cardiovascular disorders. The British Cardiovascular Society and its affiliated groups have played a central role in the development of these registries and continue to provide clinical oversight to the present day. Seven of the UK's national registries are now integrated under the management of the National Institute for Cardiovascular Outcomes Research (NICOR) that currently holds records on nearly 6.5 million episodes of care since 1990. This represents a substantial data resource for national audit that has driven up standards of cardiovascular care in the UK with a palpable impact on patient outcomes. The registries have also spawned an impressive programme of research providing novel insights into the epidemiology of cardiovascular disease. Linkage with other datasets and international collaborations create the environment for new outputs, new opportunities for 'big data' research and new ways of performing clinical trials. As the centenary of the British Cardiac Society (now British Cardiovascular Society) approaches, its role in the development of the UK's cardiovascular audits can be counted as one of its outstanding achievements. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
24. Cardiac surgery and congenital heart disease: reflections on a modern revolution.
- Author
-
Lim, Joanna Catherine Ee-Sien, Elliott, Martin John, Wallwork, John, and Keogh, Bruce
- Subjects
CONGENITAL heart disease ,CARDIAC surgery ,HEART valve prosthesis implantation ,TRANSPOSITION of great vessels ,CARDIOPULMONARY bypass ,ATRIAL septal defects ,PATENT ductus arteriosus ,HEART valve diseases - Abstract
The success of cardiac surgery has transformed the prospects of children with congenital heart disease with over 90% now surviving to adulthood. The early pioneering surgeons took on significant risk, whilst current surgical practice emphasises safety and consistency. In this article we review important British contributions to the field and consider challenges for the future, specifically how to better manage and reduce the adverse sequelae of congenital cardiac surgery by continuing to innovate safely. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
25. Sacubitril/valsartan in the treatment of systemic right ventricular failure.
- Author
-
Zandstra, Tjitske E., Nederend, Marieke, Jongbloed, Monique R. M., Kiès, Philippine, Vliegen, Hubert W., Bouma, Berto J., Tops, Laurens F., Schalij, Martin J., and Egorova, Anastasia D.
- Subjects
TRANSPOSITION of great vessels ,VALSARTAN ,ENTRESTO ,COGNITIVE ability ,QUALITY of life ,AMINOBUTYRIC acid ,ECHOCARDIOGRAPHY ,RESEARCH ,COMBINATION drug therapy ,RIGHT heart ventricle ,RESEARCH methodology ,BIPHENYL compounds ,RETROSPECTIVE studies ,MEDICAL cooperation ,EVALUATION research ,TREATMENT effectiveness ,COMPARATIVE studies ,HEART physiology ,ANGIOTENSIN receptors ,HEART failure ,LONGITUDINAL method - Abstract
Objective: Pharmacological options for patients with a failing systemic right ventricle (RV) in the context of transposition of the great arteries (TGA) after atrial switch or congenitally corrected TGA (ccTGA) are not well defined. This study aims to investigate the feasibility and effects of sacubitril/valsartan treatment in a single-centre cohort of patients.Methods: Data on all consecutive adult patients (n=20, mean age 46 years, 50% women) with a failing systemic RV in a biventricular circulation treated with sacubitril/valsartan in our centre are reported. Patients with a systemic RV ejection fraction of ≤35% who were symptomatic despite treatment with β-blocker and ACE-inhibitor/angiotensin II receptor-blockers were started on sacubitril/valsartan. This cohort underwent structural follow-up including echocardiography, exercise testing, laboratory investigations and quality of life (QOL) assessment.Results: Six-month follow-up data were available in 18 out of 20 patients, including 12 (67%) patients with TGA after atrial switch and 6 (33%) patients with ccTGA. N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) decreased significantly (950-358 ng/L, p<0.001). Echocardiographic systemic RV fractional area change and global longitudinal strain showed small improvements (19%-22%, p<0.001 and -11% to -13%, p=0.014, respectively). The 6 min walking distance improved significantly from an average of 564 to 600 m (p=0.011). The QOL domains of cognitive function, sleep and vitality improved (p=0.015, p=0.007 and p=0.037, respectively).Conclusions: We describe the first patient cohort with systemic RV failure treated with sacubitril/valsartan. Treatment appears feasible with improvements in NT-pro-BNP and echocardiographic function. Our positive results show the potential of sacubitril/valsartan for this patient population. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
26. Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease.
- Author
-
Campens, Laurence, Baris, Lucia, Scott, Nandita S., Broberg, Craig S., Bondue, Antione, Jondeau, Guillaume, Grewal, Jasmine, Johnson, Mark R., Hall, Roger, De Backer, Julie, Roos-Hesselink, Jolien W., and ROPAC investigators group
- Subjects
AORTIC dissection ,PREGNANCY outcomes ,AORTA ,CONGENITAL heart disease ,CONGENITAL disorders ,EHLERS-Danlos syndrome ,MARFAN syndrome ,HEART disease epidemiology ,CAUSES of death ,RESEARCH ,CARDIOVASCULAR diseases in pregnancy ,AORTIC diseases ,RESEARCH methodology ,ACQUISITION of data ,THORACIC aorta ,DISEASE incidence ,WORLD health ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,COMORBIDITY ,LONGITUDINAL method - Abstract
Background: Cardiovascular disease is the leading cause of death during pregnancy with thoracic aortic dissection being one of the main causes. Thoracic aortic disease is commonly related to hereditary disorders and congenital heart malformations such as bicuspid aortic valve (BAV). Pregnancy is considered a high risk period in women with underlying aortopathy.Methods: The ESC EORP Registry Of Pregnancy And Cardiac disease (ROPAC) is a prospective global registry that enrolled 5739 women with pre-existing cardiac disease. With this analysis, we aim to study the maternal and fetal outcome of pregnancy in women with thoracic aortic disease.Results: Thoracic aortic disease was reported in 189 women (3.3%). Half of them were patients with Marfan syndrome (MFS), 26% had a BAV, 8% Turner syndrome, 2% vascular Ehlers-Danlos syndrome and 11% had no underlying genetic defect or associated congenital heart defect. Aortic dilatation was reported in 58% of patients and 6% had a history of aortic dissection. Four patients, of whom three were patients with MFS, had an acute aortic dissection (three type A and one type B aortic dissection) without maternal or fetal mortality. No complications occurred in women with a history of aortic dissection. There was no significant difference in median fetal birth weight if treated with a beta-blocker or not (2960 g (2358-3390 g) vs 3270 g (2750-3570 g), p value 0.25).Conclusion: This ancillary analysis provides the largest prospective data review on pregnancy risk for patients with thoracic aortic disease. Overall pregnancy outcomes in women with thoracic aortic disease followed according to current guidelines are good. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
27. Heart failure management in adults with congenital heart disease: are we on the 'right path'?
- Author
-
Fusco, Flavia and Scognamiglio, Giancarlo
- Subjects
TRANSPOSITION of great vessels ,CONGENITAL heart disease ,HEART failure ,GLOBAL longitudinal strain - Published
- 2023
- Full Text
- View/download PDF
28. Clinical outcome of COVID-19 in patients with adult congenital heart disease.
- Author
-
Schwerzmann, Markus, Ruperti-Repilado, Francisco Javier, Baumgartner, Helmut, Bouma, Berto, Bouchardy, Judith, Budts, Werner, Campens, Laurence, Chessa, Massimo, del CerroMarin, Maria Jesús, Gabriel, Harald, Gallego, Pastora, Garcia-Orta, Rocio, Gonzalez, Ana Elvira, Schophuus Jensen, Annette, Ladouceur, Magalie, Miranda-Barrio, Berta, Morissens, Marielle, Pasquet, Agnes, Rueda, Joaquín, and van den Bosch, Annemien E.
- Subjects
CONGENITAL heart disease ,COVID-19 ,HEART failure ,ADULTS ,TREATMENT effectiveness ,SCIMITAR syndrome - Abstract
Aims: Patients with adult congenital heart disease (ACHD) are a potentially vulnerable patient cohort in case of COVID-19. Some cardiac defects may be associated with a poor COVID-19 outcome. Risk estimation in ACHD is currently based on expert opinion. The aim of this study was to collect clinical outcome data and to identify risk factors for a complicated course of COVID-19 in patients with ACHD.Methods: Twenty-five ACHD centres in nine European countries participated in the study. Consecutive patients with ACHD diagnosed with COVID-19 presenting to one of the participating centres between 27 March and 6 June 2020 were included. A complicated disease course was defined as hospitalisation for COVID-19 requiring non-invasive or invasive ventilation and/or inotropic support, or a fatal outcome.Results: Of 105 patients with a mean age of 38±13 years (58% women), 13 had a complicated disease course, of whom 5 died. In univariable analysis, age (OR 1.3, 95% CI 1.1 to 1.7, per 5 years), ≥2 comorbidities (OR 7.1, 95% CI 2.1 to 24.5), body mass index of >25 kg/m2 (OR 7.2, 95% CI 1.9 to 28.3) and cyanotic heart disease (OR 13.2, 95% CI 2.5 to 68.4) were associated with a complicated disease course. In a multivariable logistic regression model, cyanotic heart disease was the most important predictor (OR 60.0, 95% CI 7.6 to 474.0).Conclusions: Among patients with ACHD, general risk factors (age, obesity and multiple comorbidities) are associated with an increased risk of complicated COVID-19 course. Congenital cardiac defects at particularly high risk were cyanotic lesions, including unrepaired cyanotic defects or Eisenmenger syndrome. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
29. Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia.
- Author
-
Diller, Gerhard-Paul, Enders, Dominic, Lammers, Astrid E., Orwat, Stefan, Schmidt, Renate, Radke, Robert M., Gerss, Joachim, De Torres Alba, Fernando, Kaleschke, Gerrit, Bauer, Ulrike M., Marschall, Ursula, and Baumgartner, Helmut
- Subjects
INFLUENZA ,CONGENITAL heart disease ,CARDIAC patients ,VIRUS diseases ,COVID-19 ,OLDER patients - Abstract
Objectives: Data on the clinical outcome of patients with congenital heart disease (CHD) affected by severe viral pneumonia are limited. We analysed morbidity and mortality of viral pneumonia and evaluated the association between medical conditions, medication, vaccination and outcome specifically in patients with CHD requiring hospitalisation for viral pneumonia.Methods: Based on data from one of Germany's largest health insurers, all cases of viral pneumonia requiring hospital admission (2005-2018) were studied. Mortality, and composites of death, transplantation, mechanical circulatory support, ventilation or extracorporeal lung support served as endpoints.Results: Overall, 26 262 viral pneumonia cases occurred in 24 980 patients. Of these, 1180 cases occurred in patients with CHD. Compared with patients without CHD, mortality rate was elevated in patients with CHD. As a group, patients with CHD aged 20-59 years even exceeded mortality rates in patients without CHD aged >60 years. No mortality was observed in patients with CHD with simple defects <60 years of age without associated cardiovascular risk factors. On multivariable logistic regression analysis, age, CHD complexity, chromosomal anomalies, cardiac medication, use of immunosuppressants and absence of vaccination for influenza emerged as risk factors of adverse outcome.Conclusions: We present timely data on morbidity and mortality of severe viral pneumonia requiring hospital admission in patients with CHD. Need for mechanical ventilation and risk of death in CHD increase early in life, reaching a level equivalent to non-CHD individuals >60 years of age. Our data suggest that except for patients with isolated simple defects, patients with CHD should be considered higher-risk individuals when faced with severe viral pneumonia. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
30. Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
- Author
-
Peng Fan, Ying Zhang, Yi-Ting Lu, Kun-Qi Yang, Pei-Pei Lu, Qiong-Yu Zhang, Fang Luo, Ya-Hui Lin, Xian-Liang Zhou, Tao Tian, Fan, Peng, Zhang, Ying, Lu, Yi-Ting, Yang, Kun-Qi, Lu, Pei-Pei, Zhang, Qiong-Yu, Luo, Fang, Lin, Ya-Hui, Zhou, Xian-Liang, and Tian, Tao
- Subjects
HEART failure ,ARRHYTHMIA ,PROGNOSIS ,PREPROENDOTHELIN ,CARDIOMYOPATHIES ,HEART transplantation ,RESEARCH ,ENDOTHELINS ,RESEARCH methodology ,CONGENITAL heart disease ,MAGNETIC resonance imaging ,IMPLANTABLE cardioverter-defibrillators ,MEDICAL cooperation ,EVALUATION research ,VENTRICULAR tachycardia ,HEART ventricles ,COMPARATIVE studies ,CARDIAC arrest ,VENTRICULAR fibrillation ,PEPTIDE hormones ,STROKE volume (Cardiac output) ,LONGITUDINAL method ,PEPTIDES ,DISEASE complications - Abstract
Objective: To determine the prognostic role of big endothelin-1 (ET-1) in left ventricular non-compaction cardiomyopathy (LVNC).Methods: We prospectively enrolled patients whose LVNC was diagnosed by cardiac MRI and who had big ET-1 data available. Primary end point was a composite of all-cause mortality, heart transplantation, sustained ventricular tachycardia/fibrillation and implanted cardioverter defibrillator discharge. Secondary end point was cardiac death or heart transplantation.Results: Altogether, 203 patients (median age 44 years; 70.9% male) were divided into high-level (≥0.42 pmol/L) and low-level (<0.42 pmol/L) big ET-1 groups according to the median value of plasma big ET-1 levels. Ln big ET-1 was positively associated with Ln N-terminal pro-brain natriuretic peptide, left ventricular diameter, but negatively related to age and Ln left ventricular ejection fraction. Median follow-up was 1.9 years (IQR 0.9-3.1 years). Kaplan-Meier analysis showed that, compared with patients with low levels of big ET-1, those with high levels were at greater risk for meeting both primary (p<0.001) and secondary (p<0.001) end points. The C-statistic estimation of Ln big ET-1 for predicting the primary outcome was 0.755 (95% CI 0.685 to 0.824, p<0.001). After adjusting for confounding factors, Ln big ET-1 was identified as an independent predictor of the composite primary outcome (HR 1.83, 95% CI 1.27 to 2.62, p=0.001) and secondary outcome (HR 1.93, 95% CI 1.32 to 2.83, p=0.001).Conclusions: Plasma big ET-1 may be a valuable index to predict the clinical adverse outcomes in patients with LVNC. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
31. Greater admissions, mortality and cost of heart failure in adults with congenital heart disease.
- Author
-
Burstein, Danielle S., Rossano, Joseph W., Griffis, Heather, Xuemei Zhang, Fowler, Rachel, Frischertz, Benjamin, Kim, Yuli Y., Lindenfield, JoAnn, Mazurek, Jeremy A., Edelson, Jonathan B., Menachem, Jonathan N., and Zhang, Xuemei
- Subjects
HEART failure ,CONGENITAL heart disease ,INTRA-aortic balloon counterpulsation ,ADULTS ,ATRIAL septal defects - Abstract
Objective: Limited contemporary data exist regarding outcomes and resource use among adults with congenital heart disease and heart failure (ACHD-HF). This study compared outcomes, emergency department (ED) and hospital resource use, and advanced heart failure (HF) therapies in ACHD-HF versus non-ACHD with HF (HF-non-ACHD).Methods: The Nationwide Emergency Department Sample and Nationwide Inpatient Sample were used to analyse outcomes and resource use among ACHD-HF ED visits and hospitalisations from 2006 to 2016. ACHD-HF was stratified by single-ventricle (SV) and two-ventricle (2V) disease.Results: A total of 76 557 ACHD-HF visits (3.6% SV physiology) and 31 137 414 HF-non-ACHD visits were analysed. ACHD-HFs were younger (SV 33 years (IQR 25-44), 2V 62 years (IQR 45-76); HF-non-ACHD 74 years (IQR 63-83); p<0.001). ACHD-HFs had higher ED admissions (78% vs 70%, p<0.001), longer hospital length of stay (5 days (IQR 2-8) vs 4 days (IQR 2-7), p<0.001) and greater hospital costs ($49K (IQR 2K-121K) vs $32K (17K-66K), p<0.001). Mortality was significantly higher among ACHD-HFs with SV physiology (6.6%; OR 1.6, 95% CI 1.1 to 2.3) or 2V physiology (6.3%; OR 1.4, 95% CI 1.3 to 1.5) versus HF-non-ACHD (5.5%). ACHF-HF hospitalisations increased more (46% vs 6% HF-non-ACHD) over a 10-year period, but the proportion receiving ventricular assist device (VAD) (ACHD-HF -2% vs HF-non-ACHD 294%) or transplant (ACHD-HF -37% vs HF-non-ACHD 73%) decreased.Conclusion: ACHD-HFs have significant ED and hospital resource use that has increased over the past 10 years. However, advanced HF therapies (VAD and transplantation) are less commonly used compared with those without adult congenital heart disease. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
32. Prognostic value of C-reactive protein in adults with congenital heart disease.
- Author
-
Geenen, Laurie W., Baggen, Vivan J. M., van den Bosch, Annemien E., Eindhoven, Jannet A., Kauling, Robert M., Cuypers, Judith A. A. E., Roos Hesselink, Jolien W., and Boersma, Eric
- Subjects
TRANSPOSITION of great vessels ,CONGENITAL heart disease ,PROGNOSIS ,C-reactive protein ,ADULTS ,ACUTE phase proteins - Abstract
Background: High-sensitivity C reactive protein (hs-CRP) has been associated with outcomes in adult congenital heart disease (ACHD). However, its prognostic value beyond N-terminal pro B type natriuretic peptide (NT-proBNP) or troponin T remains unknown. We studied the temporal evolution of hs-CRP, as well as the relation between hs-CRP and adverse clinical outcomes independent of NT-proBNP and troponin T in patients with ACHD.Methods: In this prospective cohort study, we enrolled 602 patients with ACHD (2011-2013) who underwent baseline and thereafter annual blood sampling during 4 years. Hs-CRP, hs-troponin T and NT-proBNP were measured. The primary endpoint was composed of death or heart failure (HF). Cox regression and Joint Modelling was used to relate 2log hs-CRP levels with the endpoint, with adjustment for baseline characteristics and (repeated) hs-troponin T and NT-proBNP measurements.Results: Hs-CRP was measured at baseline in 591 patients, median age 33 years, 58% men, 90% New York Heart Association I with an average of 4.3 measurements per patient. Median follow-up was 5.9 (IQR 5.3-6.3) years (99.2% complete) and 69 patients met the endpoint. Higher baseline hs-CRP was independently associated with higher risk of death or HF (HR 1.36, 95% CI 1.19 to 1.55). Hs-CRP increased over time prior to death or HF, and repeated hs-CRP measurements were associated with the endpoint, independent of repeated NT-proBNP and hs-troponin T (HR 1.54, 95% CI 1.24 to 1.98).Conclusions: Hs-CRP carries incremental prognostic value for the risk of death or HF, beyond NT-proBNP and hs-troponin T. Hs-CRP increased prior to the occurrence of HF or death, supporting the role of inflammation in the clinical deterioration of patients with ACHD. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
33. Pregnancy outcomes in women with aortic coarctation.
- Author
-
Ramlakhan, Karishma P., Tobler, Daniel, Greutmann, Matthias, Schwerzmann, Markus, Baris, Lucia, Yetman, Anji T., Nihoyannopoulos, Petros, Manga, Pravin, Boersma, Eric, Maggioni, Aldo P., Johnson, Mark R., Hall, Roger, Roos-Hesselink, Jolien W., and ROPAC investigators group
- Subjects
AORTIC coarctation ,PREGNANCY outcomes ,VENTRICULAR ejection fraction ,CONGENITAL heart disease ,HIGH-risk pregnancy ,PREGNANCY complications - Abstract
Objective: Pregnancy in women with aortic coarctation (CoA) has an estimated moderately increased risk (mWHO II-III) of adverse cardiovascular, obstetric or fetal events, but prospective data to validate this risk classification are scarce. We examined pregnancy outcomes and identified associations with adverse outcomes.Methods: Pregnancies in women with CoA were selected from the worldwide prospective Registry of Pregnancy and Cardiac Disease (ROPAC, n=303 out of 5739), part of the European Society of Cardiology EURObservational Research Programme. The frequency of and associations with major adverse cardiac events (MACE) and hypertensive disorders (pregnancy-induced hypertension, (pre-)eclampsia or haemolysis, elevated liver enzymes and low platelets syndrome) were analysed.Results: Of 303 pregnancies (mean age 30 years, pregnancy duration 39 weeks), 9.6% involved unrepaired CoA and 27.1% were in women with pre-existing hypertension. No maternal deaths or aortic dissections occurred. MACE occurred in 13 pregnancies (4.3%), of which 10 cases were of heart failure (3.3%). Univariable associations with MACE included prepregnancy clinical signs of heart failure (OR 31.8, 95% CI 6.8 to 147.7), left ventricular ejection fraction <40% (OR 10.4, 95% CI 1.8 to 59.5), New York Heart Association class >1 (OR 11.4, 95% CI 3.6 to 36.3) and cardiac medication use (OR 4.9, 95% CI 1.3 to 18.3). Hypertensive disorders of pregnancy occurred in 16 (5.3%), cardiac medication use being their only predictor (OR 3.2, 95% CI 1.1 to 9.6). Premature births were 9.1%, caesarean section was performed in 49.7% of pregnancies. Of 4 neonatal deaths, 3 were after spontaneous extreme preterm birth.Conclusions: The ROPAC data show low MACE and hypertensive disorder rates during pregnancy in women with CoA, suggesting pregnancy to be more safe and better tolerated than previously appreciated. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
34. Predictors of low exercise cardiac output in patients with severe pulmonic regurgitation.
- Author
-
Karsenty, Clément, Khraiche, Diala, Jais, Jean Philippe, Raimondi, Francesca, Ladouceur, Magalie, Waldmann, Victor, Soulat, Gilles, Pontnau, Florence, Bonnet, Damien, Iserin, Laurence, and Legendre, Antoine
- Subjects
CARDIAC output ,CARDIAC patients ,CONGENITAL heart disease ,OXYGEN consumption ,EXERCISE - Abstract
Background and Objectives: Chronic pulmonic regurgitation (PR) following repair of congenital heart disease (CHD) impairs right ventricular function that impacts peak exercise cardiac index (pCI). We aimed to estimate in a non-invasive way pCI and peak oxygen consumption (pVO2) and to evaluate predictors of low pCI in patients with significant residual pulmonic regurgitation after CHD repair.Method: We included 82 patients (median age 19 years (range 10-54 years)) with residual pulmonic regurgitation fraction >40%. All underwent cardiac MRI and cardiopulmonary testing with measurement of pCI by thoracic impedancemetry. Low pCI was defined <7 L/min/m2.Results: Low pCI was found in 18/82 patients. Peak indexed stroke volume (pSVi) tended to compensate chronotropic insufficiency only in patients with normal pCI (r=-0.31, p=0.01). Below 20 years of age, only 5/45 patients had low pCI but near-normal (≥6.5 L/min/m2). pVO2 (mL/kg/min) was correlated with pCI (r=0.58, p=0.0002) only in patients aged >20 years. Left ventricular stroke volume in MRI correlated with pSVi only in the group of patients with low pCI (r=0.54, p=0.02). No MRI measurements predicted low pCI. In multivariable analysis, only age predicted a low pCI (OR=1.082, 95% CI 1.035 to 1.131, p=0.001) with continuous increase of risk with age.Conclusions: In patients with severe PR, pVO2 is a partial reflection of pCI. Risk of low pCI increases with age. No resting MRI measurement predicts low haemodynamic response to exercise. Probably more suitable to detect ventricular dysfunction, pCI measurement could be an additional parameter to take into account when considering pulmonic valve replacement. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
35. Advanced heart failure and transplant in congenital heart disease.
- Author
-
Reardon, Leigh and Lin, Jeannette
- Subjects
AORTIC coarctation ,ATRIAL septal defects ,CONGENITAL heart disease ,HEART transplantation ,TRICUSPID valve surgery ,IMPLANTABLE cardioverter-defibrillators ,HEART failure ,SCIMITAR syndrome ,SEVERITY of illness index ,DISEASE complications - Published
- 2021
- Full Text
- View/download PDF
36. Neurocognitive and psychosocial outcomes in adult congenital heart disease: a lifespan approach.
- Author
-
Kovacs, Adrienne H. and Bellinger, David C.
- Subjects
22Q11 deletion syndrome ,CONGENITAL heart disease ,TRANSPOSITION of great vessels ,MENTAL health services ,PSYCHOLOGICAL well-being ,PSYCHOTHERAPY ,MEDICAL personnel ,LONELINESS - Published
- 2021
- Full Text
- View/download PDF
37. Predicting sudden cardiac death in adults with congenital heart disease.
- Author
-
Oliver, Jose M., Gallego, Pastora, Gonzalez, Ana Elvira, Avila, Pablo, Alonso, Andres, Garcia-Hamilton, Diego, Peinado, Rafael, Dos-Subirà, Laura, Pijuan-Domenech, Antonia, Rueda, Joaquín, odriguez-Puras, Maria-Jose, Garcia-Orta, Rocio, Martínez-Quintana, Efrén, Datino, Tomas, Fernandez-Aviles, Francisco, Bermejo, Javier, Rodriguez-Puras, Maria-Jose, and Spanish ACHD Network
- Subjects
CONGENITAL heart disease ,PULMONARY atresia ,CARDIAC arrest ,TRANSPOSITION of great vessels ,FORECASTING ,MYOCARDIAL infarction ,RESEARCH ,RESEARCH methodology ,PROGNOSIS ,CASE-control method ,DISEASE incidence ,MEDICAL cooperation ,EVALUATION research ,RISK assessment ,COMPARATIVE studies ,LOGISTIC regression analysis ,LONGITUDINAL method ,DISEASE complications - Abstract
Objectives: To develop, calibrate, test and validate a logistic regression model for accurate risk prediction of sudden cardiac death (SCD) and non-fatal sudden cardiac arrest (SCA) in adults with congenital heart disease (ACHD), based on baseline lesion-specific risk stratification and individual's characteristics, to guide primary prevention strategies.Methods: We combined data from a single-centre cohort of 3311 consecutive ACHD patients (50% male) at 25-year follow-up with 71 events (53 SCD and 18 non-fatal SCA) and a multicentre case-control group with 207 cases (110 SCD and 97 non-fatal SCA) and 2287 consecutive controls (50% males). Cumulative incidences of events up to 20 years for specific lesions were determined in the prospective cohort. Risk model and its 5-year risk predictions were derived by logistic regression modelling, using separate development (18 centres: 144 cases and 1501 controls) and validation (two centres: 63 cases and 786 controls) datasets.Results: According to the combined SCD/SCA cumulative 20 years incidence, a lesion-specific stratification into four clusters-very-low (<1%), low (1%-4%), moderate (4%-12%) and high (>12%)-was built. Multivariable predictors were lesion-specific cluster, young age, male sex, unexplained syncope, ischaemic heart disease, non-life threatening ventricular arrhythmias, QRS duration and ventricular systolic dysfunction or hypertrophy. The model very accurately discriminated (C-index 0.91; 95% CI 0.88 to 0.94) and calibrated (p=0.3 for observed vs expected proportions) in the validation dataset. Compared with current guidelines approach, sensitivity increases 29% with less than 1% change in specificity.Conclusions: Predicting the risk of SCD/SCA in ACHD can be significantly improved using a baseline lesion-specific stratification and simple clinical variables. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
38. Pregnancy in congenital heart disease: risk prediction and counselling.
- Author
-
van Hagen, Iris M. and Roos-Hesselink, Jolien W.
- Subjects
CONGENITAL heart disease ,AORTIC coarctation ,ECLAMPSIA ,FETAL echocardiography ,VENTRICULAR ejection fraction ,PREGNANCY ,FORECASTING ,PREGNANCY complications ,COUNSELING ,CARDIOVASCULAR diseases in pregnancy ,MEDICAL care ,PATIENTS ,HIGH-risk pregnancy ,RISK assessment - Published
- 2020
- Full Text
- View/download PDF
39. Heart block in a young man.
- Author
-
Singh, Vickram, Edwards, Heather J., and Leong, Fong T.
- Subjects
TRANSPOSITION of great vessels ,HEART block ,HEART conduction system ,YOUNG men ,RHEUMATIC fever ,ATRIOVENTRICULAR node ,HIS bundle - Published
- 2020
- Full Text
- View/download PDF
40. Eisenmenger syndrome: diagnosis, prognosis and clinical management.
- Author
-
Arvanitaki, Alexandra, Giannakoulas, George, Baumgartner, Helmut, and Lammers, Astrid Elisabeth
- Subjects
EISENMENGER syndrome ,ATRIAL septal defects ,BRUGADA syndrome ,AEROBIC capacity ,VASCULAR remodeling ,CONGENITAL heart disease - Abstract
Eisenmenger syndrome (ES) represents the most severe phenotype of pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD) and occurs in patients with large unrepaired shunts. Despite early detection of CHD and major advances in paediatric cardiac surgery, ES is still prevalent and requires a multidisciplinary approach by adult CHD experts in tertiary centres. Central cyanosis is the primary clinical manifestation leading to secondary erythrocytosis and various multiorgan complications that increase morbidity and affect quality of life. Close follow-up is needed to early diagnose and timely manage these complications. The primary goal of care is to maintain patients' fragile stability. Although the recent use of advanced PAH therapies has substantially improved functional capacity and increased life expectancy, long-term survival remains poor. Progressive heart failure, infectious diseases and sudden cardiac death comprise the main causes of death in patients with ES. Impaired exercise tolerance, decreased arterial oxygen saturation, iron deficiency, pre-tricuspid shunts, arrhythmias, increased brain natriuretic peptide, echocardiographic indices of right ventricular dysfunction and hospitalisation for heart failure predict mortality. Endothelin receptor antagonists are used as first-line treatment in symptomatic patients, while phosphodiesterase-5 inhibitors may be added. Due to the lack of evidence, current guidelines do not provide a clear therapeutic strategy regarding treatment escalation. Additional well-designed trials are required to assess the comparative efficacy of various PAH agents and the benefit of combination therapy. Finally, the development of a risk score is of utmost importance to guide clinical therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
41. Utility of 3D printed cardiac models in congenital heart disease: a scoping review.
- Author
-
Illmann, Caroline F., Ghadiry-Tavi, Rouzbeh, Hosking, Martin, and Harris, Kevin C.
- Subjects
CONGENITAL heart disease ,MEDICAL personnel as patients ,AORTIC coarctation ,MEDICAL simulation ,MEDICAL subject headings ,ALLIED health personnel ,CARDIOLOGISTS ,COMPUTER simulation ,THREE-dimensional printing - Abstract
Objective: Three-dimensional printing (3DP) is a novel technology with applications in healthcare, particularly for congenital heart disease (CHD). We sought to explore the spectrum of use of 3D printed CHD models (3D-CM) and identify knowledge gaps within the published body of literature to guide future research.Methods: We conducted a scoping review targeting published literature on the use of 3D-CMs. The databases of MEDLINE, EMBASE and Web of Science were searched from their inception until 19 July 2019. Inclusion criteria were primary research; studies reporting use of 3D-CMs; and human subjects. Exclusion criteria were studies where 3D-CMs were generated for proof of concept but not used; and studies focused on bioprinting or computational 3D-CMs. Studies were assessed for inclusion and data were extracted from eligible articles in duplicate.Results: The search returned 648 results. Following assessment, 79 articles were included in the final qualitative synthesis. The majority (66%) of studies are case reports or series. 15% reported use of a control group. Three main areas of utilisation are for (1) surgical and interventional cardiology procedural planning (n=62), (2) simulation (n=25), and (3) education for medical personnel or patients and their families (n=17). Multiple studies used 3D-CMs for more than one of these areas.Conclusions: 3DP for CHD is a new technology with an evolving literature base. Most of the published literature are experiential reports as opposed to manuscripts on scientifically robust studies. Our study has identified gaps in the literature and addressed priority areas for future research. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
42. Cardiac catheter intervention complexity and safety outcomes in adult congenital heart disease.
- Author
-
Brida, Margarita, Diller, Gerhard Paul, Nashat, Heba, Barracano, Rosaria, Kempny, Aleksander, Uebing, Anselm, Rigby, Michael L., and Gatzoulis, Michael A.
- Subjects
CONGENITAL heart disease ,ATRIAL septal defects ,CATHETERS ,TRICUSPID valve ,PATENT ductus arteriosus ,PULMONARY stenosis - Abstract
Objective: To describe the intervention spectrum, complexity, and safety outcomes of catheter-based interventions in a contemporary adult congenital heart disease (ACHD) tertiary cohort.Methods: All patients over 16 years who underwent a catheter-based intervention for ACHD in our centre between 2000 and 2016 were included. Baseline demographics, clinical characteristics, indications for and complexity of intervention, procedural complications and early and mid-term mortality were analysed.Results: Overall, 1644 catheter-based interventions were performed. Intervention complexity ranged from simple (67.5%) to intermediate (26.4%) and to high (6.1%). Commonly performed procedures were atrial septal defect (33.4%) and patent foramen ovale closure (26.1%) followed by coarctation of the aorta (11.1%) and pulmonary artery interventions (7.0%). Age at index intervention was 40±16 years, 758 (46.1%) patients were male, 73.2% in New York Heart Association (NYHA) class I, 20.2% in NYHA class II, whereas 6.6% in NYHA class III/IV. In-hospital mortality was 0.7%. Median postinterventional length of stay was 1 day. Complications occurred in 129 (7.9%) with major adverse events in 21 (1.3%). One-year postintervention survival rates were 98.7% (95% CI 98.2 to 99.2). Over the study period, there was a notable shift in intervention complexity, with a predominance of simple procedures performed in early years and more complex procedures in later years. Furthermore, the case mix during the study broadened (p<0.001) with new catheter-based interventions and a more individualised approach to therapy.Conclusion: This study shows an increasing complexity and expanding variability of ACHD catheter-based interventions, associated with low major complications, short hospital stays and low early and mid-term mortality. Ongoing investment in ACHD catheter interventions is warranted. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
43. Adult congenital heart disease and the COVID-19 pandemic.
- Author
-
Radke, Robert M., Frenzel, Tim, Baumgartner, Helmut, and Diller, Gerhard-Paul
- Subjects
TRANSPOSITION of great vessels ,COVID-19 pandemic ,CONGENITAL heart disease ,COVID-19 ,BLOOD cell count - Abstract
Adults with congenital heart disease (ACHD) may be at high risk in the case of COVID-19. Due to the heterogeneity of ACHD and secondary complications, risk profiles are, however, not uniform. This document aims to give an overview of relevant data and outline our pragmatic approach to disease prevention and management. Based on anatomy and additional physiological factors including symptoms, exercise capacity, heart failure, pulmonary hypertension and cyanosis, we propose a pragmatic approach to categorising patients into low-risk, intermediate-risk and high-risk groups. We regard especially patients with complex cyanotic conditions, those with palliated univentricular hearts, heart failure, severe valvular disease or pulmonary hypertension as high-risk patients. To avoid infection, we recommend self-isolation and exemption from work for these cohorts. Infected ACHD patients with low or moderate risk and without signs of deterioration may be remotely followed and cared for at home while in self isolation. High-risk patients or those with signs of respiratory or cardiovascular impairment require admission ideally at a tertiary ACHD centre. Especially patients with complex, cyanotic disease, heart failure and arrhythmias require particular attention. Treatment in patients with cyanotic heart disease should be guided by the relative degree of desaturation compared with baseline and lactate levels rather than absolute oxygen saturation levels. Patients with right heart dilatation or dysfunction are potentially at increased risk of right heart failure as mechanical ventilation and acute respiratory distress syndrome can lead to increase in pulmonary arterial pressures. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
44. Implantable cardiac electronic device therapy for patients with a systemic right ventricle.
- Author
-
Barracano, Rosaria, Brida, Margarita, Guarguagli, Silvia, Palmieri, Rosalinda, Diller, Gerhard Paul, Gatzoulis, Michael A., and Wong, Tom
- Subjects
IMPLANTABLE cardioverter-defibrillators ,PATIENTS' rights ,ELECTRONIC equipment ,CONGENITAL heart disease ,TRANSPOSITION of great vessels ,CARDIAC arrest ,ARRHYTHMIA treatment ,CARDIAC surgery ,RIGHT heart ventricle ,CARDIAC pacing ,RISK assessment ,TREATMENT effectiveness ,HEART beat ,ACTION potentials ,ELECTRIC countershock ,HEART physiology ,ARRHYTHMIA ,CARDIAC pacemakers ,HEART conduction system - Abstract
The systemic right ventricle (SRV), defined as the morphological right ventricle supporting the systemic circulation, is relatively common in congenital heart disease (CHD). Our review aimed at examining the current evidence, knowledge gaps and technical considerations regarding implantable cardiac electronic device therapy in patients with SRV. The risk of sinus node dysfunction (SND) after atrial switch repair and/or complete heart block in congenitally corrected transposition of great arteries requiring permanent pacing increases with age. Similar to acquired heart disease, indication for pacing includes symptomatic bradycardia, SND and high degree atrioventricular nodal block. Right ventricular dysfunction and heart failure also represent important complications in SRV patients. Cardiac resynchronisation therapy (CRT) has been proposed to improve systolic function in SRV patients, although indications for CRT are not well defined and its potential benefit remains uncertain. Amongst adult CHD, patients with SRV are at the highest risk for sudden cardiac death (SCD). Nevertheless, risk stratification for SCD is scarce in this cohort and implantable cardioverter-defibrillator indication is currently limited to secondary prevention. Vascular access and the incidence of device-related complications, such as infections, inappropriate shocks and device system failure, represent additional challenges to implantable cardiac electronic device therapy in patients with SRV. A multidisciplinary approach with tertiary expertise and future collaborative research are all paramount to further the care for this challenging nonetheless ever increasing cohort of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
45. Prediction of prognosis in patients with tetralogy of Fallot based on deep learning imaging analysis.
- Author
-
Diller, Gerhard Paul, Orwat, Stefan, Vahle, Julius, Bauer, Ulrike M. M., Urban, Aleksandra, Sarikouch, Samir, Berger, Felix, Beerbaum, Philipp, Baumgartner, Helmut, and German Competence Network for Congenital Heart Defects Investigators
- Subjects
VENTRICULAR ejection fraction ,DEEP learning ,TETRALOGY of Fallot ,FORECASTING ,IMAGE analysis ,VENTRICULAR tachycardia ,PROGNOSIS ,COMPUTERS in medicine ,PILOT projects ,PREDICTIVE tests ,TIME ,MAGNETIC resonance imaging ,ACQUISITION of data ,DIAGNOSTIC imaging ,RISK assessment ,ELECTROCARDIOGRAPHY ,COMPUTER-aided diagnosis ,LONGITUDINAL method - Abstract
Objective: To assess the utility of machine learning algorithms for automatically estimating prognosis in patients with repaired tetralogy of Fallot (ToF) using cardiac magnetic resonance (CMR).Methods: We included 372 patients with ToF who had undergone CMR imaging as part of a nationwide prospective study. Cine loops were retrieved and subjected to automatic deep learning (DL)-based image analysis, trained on independent, local CMR data, to derive measures of cardiac dimensions and function. This information was combined with established clinical parameters and ECG markers of prognosis.Results: Over a median follow-up period of 10 years, 23 patients experienced an endpoint of death/aborted cardiac arrest or documented ventricular tachycardia (defined as >3 documented consecutive ventricular beats). On univariate Cox analysis, various DL parameters, including right atrial median area (HR 1.11/cm², p=0.003) and right ventricular long-axis strain (HR 0.80/%, p=0.009) emerged as significant predictors of outcome. DL parameters were related to adverse outcome independently of left and right ventricular ejection fraction and peak oxygen uptake (p<0.05 for all). A composite score of enlarged right atrial area and depressed right ventricular longitudinal function identified a ToF subgroup at significantly increased risk of adverse outcome (HR 2.1/unit, p=0.007).Conclusions: We present data on the utility of machine learning algorithms trained on external imaging datasets to automatically estimate prognosis in patients with ToF. Due to the automated analysis process these two-dimensional-based algorithms may serve as surrogates for labour-intensive manually attained imaging parameters in patients with ToF. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
46. Prognostic value of von Willebrand factor in adult patients with congenital heart disease.
- Author
-
Hideo Ohuchi, Yohsuke Hayama, Hikari Miike, Dai Suzuki, Kimiko Nakajima, Toru Iwasa, Nao Konagai, Heima Sakaguchi, Aya Miyazaki, Isao Shiraishi, Ken-ichi Kurosaki, Michikazu Nakai, Ohuchi, Hideo, Hayama, Yohsuke, Miike, Hikari, Suzuki, Dai, Nakajima, Kimiko, Iwasa, Toru, Konagai, Nao, and Sakaguchi, Heima
- Subjects
CONGENITAL heart disease ,VON Willebrand factor ,CARDIAC patients ,CENTRAL venous pressure ,SERUM albumin - Abstract
Objectives: von Willebrand factor (vWF) has prognostic value in patients with heart failure (HF) and in those with liver disease. Liver congestion, due to right-sided HF (RHF), is one of the major clinical pathophysiologic manifestations in adults with congenital heart disease (ACHD). The present study's purpose was to clarify the prognostic value of plasma levels of vWF antigen (vWF:Ag) in ACHD.Methods: We measured vWF:Ag (%) in 382 consecutive patients (20 unrepaired cyanotic ACHD, 172 Fontan patients and 190 ACHD after biventricular repair) and compared the results with the clinical profiles and prognosis.Results: The plasma vWF:Ag level was 130±53 (normal range: 55%-190%), and 48 patients (13%) showed high levels of vWF:Ag (≥190%). Older age, Fontan circulation, higher central venous pressure, lower arterial oxygen saturation and lower plasma levels of albumin were independently associated with high log (vWF:Ag) (p<0.05-0.0001). During the follow-up of 2.4±1.4 years, 15 patients died. High log (vWF:Ag) predicted the all-cause mortality (HR 1.63 per 0.1, 95% CI 1.40 to 1.96, p<0.0001). Specifically, patients with high vWF:Ag (≥165%) had a substantially higher risk of all-cause mortality (HR 56.4, 95% CI 11.4 to 1020, p<0.0001), and this prognostic value was independent of plasma levels of brain-type natriuretic peptide.Conclusions: High vWF:Ag may reflect RHF severity and related liver dysfunction with a strong prognostic value of all-cause mortality in ACHD. Thus, vWF:Ag might be an excellent biomarker for monitoring ACHD with RHF. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
47. Reintervention and survival in 1428 patients in the Australian and New Zealand Fontan Registry.
- Author
-
Daley, Michael, du Plessis, Karin, Zannino, Dianna, Hornung, Tim, Disney, Patrick, Cordina, Rachael, Grigg, Leeanne, Radford, Dorothy J., Bullock, Andrew, and d'Udekem, Yves
- Abstract
Objective: Patients undergoing single-ventricle palliation have experienced significant improvement in survival in the recent era. However, a substantial proportion of these patients undergo reoperations. We performed a review of the Australia and New Zealand (ANZ) Fontan Registry to determine the overall reintervention and reoperative burden in these patients.Methods: A retrospective longitudinal cohort study was performed using data from patients who underwent a Fontan operation between 1975 and 2016 from the ANZ Fontan Registry. The data obtained included Fontan operation, reinterventions and most recent follow-up status. We examined the type and timing of reinterventions and survival.Results: Of the 1428 patients identified, 435 (30%) underwent at least one reintervention after the Fontan operation: 110 patients underwent early reintervention and 413 underwent late reinterventions. Excluding Fontan conversion and transplantation, 220 patients underwent at least one interventional procedure and 209 patients underwent at least one reoperation. Fenestration closure and pacemaker-related procedures were the most common catheter and surgical interventions, respectively. The cumulative incidence of reintervention following Fontan was 23%, 37% and 55% at 10, 20 and 30 years, respectively. Survival and freedom from failure were worse in patients requiring later reintervention after Fontan surgery (51% vs 83% and 42% vs 69%, respectively at 30 years, p<0.001). This difference persisted after excluding pacemaker-related procedures (p<0.001). Operative mortality for non-pacemaker late reoperations after Fontan was 6%.Conclusions: A substantial proportion of Fontan patients require further intervention to maintain effective single-ventricle circulation. Patients undergoing reoperation after Fontan have higher rates of mortality and failure, despite intervention. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
48. Tricuspid regurgitation severity after atrial septal defect closure or pulmonic valve replacement.
- Author
-
Martin-Garcia, Agustin C., Dimopoulos, Konstantinos, Boutsikou, Maria, Martin-Garcia, Ana, Kempny, Aleksander, Alonso-Gonzalez, Rafael, Swan, Lorna, Uebing, Anselm, Babu-Narayan, Sonya V., Luis Sanchez, Pedro, Wei Li, Shore, Darryl, Gatzoulis, Michael A., Sanchez, Pedro Luis, and Li, Wei
- Subjects
ATRIAL septal defects ,TRICUSPID valve surgery ,CONGENITAL heart disease ,TRICUSPID valve ,TRICUSPID valve diseases ,VALVES ,PULMONARY valve ,HEART valve diseases ,CARDIAC surgery ,RESEARCH ,RESEARCH methodology ,RETROSPECTIVE studies ,EVALUATION research ,MEDICAL cooperation ,SEVERITY of illness index ,COMPARATIVE studies ,PROSTHETIC heart valves ,RESEARCH funding ,DISEASE complications - Abstract
Objectives: Cardiac surgery or catheter interventions are nowadays commonly performed to reduce volume loading of the right ventricle in adults with congenital heart disease. However, little is known, on the effect of such procedures on pre-existing tricuspid regurgitation (TR). We assessed the potential reduction in the severity of TR after atrial septal defect (ASD) closure and pulmonic valve replacement (PVR).Methods: Demographics, clinical and echocardiographic characteristics of consecutive patients undergoing ASD closure or PVR between 2005 and 2014 at a single centre who had at least mild preoperative TR were collected and analysed.Results: Overall, 162 patients (mean age at intervention 41.6±16.1 years, 38.3% male) were included: 101 after ASD closure (61 transcatheter vs 40 surgical) and 61 after PVR (3 transcatheter vs 58 surgical). Only 11.1% received concomitant tricuspid valve surgery (repair). There was significant reduction in the severity of TR in the overall population, from 38 (23.5%) patients having moderate or severe TR preoperatively to only 11 (6.8%) and 20 (12.3%) at 6 months and 12 months of follow-up, respectively (McNemar p<0.0001). There was a significant reduction in tricuspid valve annular diameter (p<0.0001), coaptation distance (p<0.0001) and systolic tenting area (p<0.0001). The reduction in TR was also observed in patients who did not have concomitant tricuspid valve (TV) repair (from 15.3% to 6.9% and 11.8% at 6 and 12 months, respectively, p<0.0001). On multivariable logistic regression including all univariable predictors of residual TR at 12 months, only RA area remained in the model (OR 1.2, 95% CI 1.04 to 1.37, p=0.01).Conclusions: ASD closure and PVR are associated with a significant reduction in tricuspid regurgitation, even among patients who do not undergo concomitant tricuspid valve surgery. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
49. Three-dimensional and four-dimensional flow assessment in congenital heart disease.
- Author
-
Warmerdam, Evangeline, Krings, Gregor J., Leiner, Tim, and Grotenhuis, Heynric B.
- Subjects
CONGENITAL heart disease ,THREE-dimensional flow ,AORTIC coarctation ,COMPUTATIONAL fluid dynamics ,TETRALOGY of Fallot ,BLOOD flow ,PHYSICAL & theoretical chemistry ,THREE-dimensional imaging ,MAGNETIC resonance imaging ,DIAGNOSTIC imaging ,BLOOD circulation ,HEMODYNAMICS - Abstract
Congenital heart disease (CHD) is the most common form of congenital defects, with an incidence of 8 per 1000 births. Due to major advances in diagnostics, perioperative care and surgical techniques, the survival rate of patients with CHD has improved dramatically. Conversely, although 70%-95% of infants with CHD survive into adulthood, the rate of long-term morbidity, which often requires (repeat) intervention, has increased. Recently, the role of altered haemodynamics in cardiac development and CHD has become a subject of interest. Patients with CHD often have abnormal blood flow patterns, either due to the primary cardiac defect or as a consequence of the surgical intervention(s). Research suggests that these abnormal blood flow patterns may contribute to diminished cardiac and vascular function. Serial assessment of haemodynamic parameters in patients with CHD may allow for improved understanding of the often complex haemodynamics in these patients and thereby potentially guide the timing and nature of interventions with the aim of preventing progression of cardiovascular deterioration. In this article we will discuss two novel non-invasive four-dimensional (4D) techniques to evaluate cardiovascular haemodynamics: 4D-flow cardiac magnetic resonance and computational fluid dynamics. This review focuses on the additional value of these two modalities in the evaluation of patients with CHD with abnormal flow patterns, who could benefit from advanced haemodynamic evaluation: patients with coarctation of the aorta, bicuspid aortic valve, tetralogy of Fallot and patients after Fontan palliation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
50. Current state of home-based exercise interventions in patients with congenital heart disease: a systematic review.
- Author
-
Meyer, Michael, Brudy, Leon, García-Cuenllas, Luisa, Hager, Alfred, Ewert, Peter, Oberhoffer, Renate, and Müller, Jan
- Subjects
CONGENITAL heart disease ,CARDIAC patients ,META-analysis ,EXERCISE ,QUALITY of life ,HOME care services ,SYSTEMATIC reviews ,EXERCISE therapy - Abstract
Home-based exercise training is a promising alternative to conventional supervised training for patients with congenital heart disease (CHD). Even though the beneficial effect of exercise interventions is well established in patients with CHD, knowledge concerning variety and utility of existing programmes is still lacking. Therefore, the aim of this review is to give an overview about existing home-based exercise interventions in patients with CHD. A systematic search was performed in PubMed, Cochrane, Scopus and PEDro (2008-2018) for relevant clinical trials that provided any kind of home-based exercise with patients with CHD. All articles were identified and assessed by two independent reviewers. Seven articles with 346 paediatric CHD (18 months to 16 years) and five articles with 200 adults with CHD (21-41 years) were included. Most studies performed a supervised home-based exercise intervention with children and adolescents exercising at least three times per week with duration of 45 min for 12 weeks. Reported outcome measurements were health-related quality of life and physical activity, but mostly exercise capacity measured as peak oxygen uptake that improved in four studies (1.2%, 7%, 7.7%, 15%; p<0.05), walking distance in two (3.5%, 19.5%, p<0.05,) or walking time (2 min, p=0.003) in one. The dropout rates were high (15%), and compliance to the training programme was not reported in the majority of the studies (58%). Home-based exercise interventions are safe, feasible and a useful alternative to supervised cardiac rehabilitation for all age groups of patients with CHD. Nevertheless, training compliance represents a major challenge. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.